Literature DB >> 19507008

Role of salt and excipient properties on disproportionation in the solid-state.

Peter Guerrieri1, Lynne S Taylor.   

Abstract

PURPOSE: Approximately 50% of active pharmaceutical ingredients (APIs) are manufactured and formulated as salts, due to their enhanced dissolution rates or improved solid state properties. It is essential to maintain the appropriate solid state form of the drug during processing and over the lifetime of the product. The aim of this study was to investigate the contributing factors in the process of disproportionation, whereby the salt converts back to the free form of the drug.
METHODS: Infrared and Raman spectroscopy were used to detect and quantify the formation of free base in physical mixtures with excipients. The pH-solubility relationships were determined based on measured salt solubilities and properties of the free form.
RESULTS: The mesylate salts of two model pharmaceutical compounds were found to disproportionate to the free base form when physically mixed with certain common basic excipients and exposed to moderate relative humidities. In contrast, the napsylate salts were much more resistant to disproportionation. The napsylate salts had solubilities more than 3 orders of magnitude lower than the respective mesylate salts, and showed little to no detectable formation of free base. The mesylate salts with higher solubilities showed significant levels of conversion to the free base.
CONCLUSIONS: It appears that both the solubility and pH(max) (the pH of a solution where there is saturation of both ionized and unionized species) of the salts, as well as the base solubility, play important roles in determining the susceptibility of salts to disproportionate. The extent of conversion was also affected by excipient properties, including basicity, solubility, physical state and surface area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19507008     DOI: 10.1007/s11095-009-9918-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Effects of lyophilization on the physical characteristics and chemical stability of amorphous quinapril hydrochloride.

Authors:  Y Guo; S R Byrn; G Zografi
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Evaluation of drug physical form during granulation, tabletting and storage.

Authors:  Adrian C Williams; V Brett Cooper; Lisa Thomas; Letecia J Griffith; Catherine R Petts; Steven W Booth
Journal:  Int J Pharm       Date:  2004-05-04       Impact factor: 5.875

3.  Initial stages of water adsorption on NaCl (100) studied by scanning polarization force microscopy.

Authors:  Albert Verdaguer; G M Sacha; M Luna; D Frank Ogletree; Miquel Salmeron
Journal:  J Chem Phys       Date:  2005-09-22       Impact factor: 3.488

4.  Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.

Authors:  Erika A Zannou; Qin Ji; Yatindra M Joshi; Abu T M Serajuddin
Journal:  Int J Pharm       Date:  2007-01-09       Impact factor: 5.875

5.  Measurement of surface pH of pharmaceutical solids: a critical evaluation of indicator dye-sorption method and its comparison with slurry pH method.

Authors:  Madhu Pudipeddi; Erika A Zannou; Madhav Vasanthavada; Aruna Dontabhaktuni; Alan E Royce; Yatindra M Joshi; Abu T M Serajuddin
Journal:  J Pharm Sci       Date:  2008-05       Impact factor: 3.534

6.  Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant.

Authors:  B R Rohrs; T J Thamann; P Gao; D J Stelzer; M S Bergren; R S Chao
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

7.  Solubility of organic hydrochlorides.

Authors:  S F Kramer; G L Flynn
Journal:  J Pharm Sci       Date:  1972-12       Impact factor: 3.534

8.  Solubility of doxycycline in aqueous solution.

Authors:  J B Bogardus; R K Blackwood
Journal:  J Pharm Sci       Date:  1979-02       Impact factor: 3.534

9.  An investigation into the influence of counterion on the properties of some amorphous organic salts.

Authors:  Christopher S Towler; Tonglei Li; Håkan Wikström; David M Remick; Manuel V Sanchez-Felix; Lynne S Taylor
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

Review 10.  Salt formation to improve drug solubility.

Authors:  Abu T M Serajuddin
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

View more
  10 in total

1.  Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins.

Authors:  Neeraj Kumar; Gulshan Bansal; Sandeep Kumar; Asim Kumar Jana
Journal:  AAPS PharmSciTech       Date:  2012-06-06       Impact factor: 3.246

Review 2.  Impact of excipient interactions on solid dosage form stability.

Authors:  Ajit S Narang; Divyakant Desai; Sherif Badawy
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

3.  Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.

Authors:  Yi-Ling Hsieh; Jeremy M Merritt; Weili Yu; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-04-15       Impact factor: 4.200

4.  Utility of Physiologically Based Pharmacokinetic Absorption Modeling to Predict the Impact of Salt-to-Base Conversion on Prasugrel HCl Product Bioequivalence in the Presence of Proton Pump Inhibitors.

Authors:  Jianghong Fan; Xinyuan Zhang; Liang Zhao
Journal:  AAPS J       Date:  2017-07-14       Impact factor: 4.009

5.  Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.

Authors:  Jeremy M Merritt; Shekhar K Viswanath; Gregory A Stephenson
Journal:  Pharm Res       Date:  2012-08-24       Impact factor: 4.200

Review 6.  Preclinical formulations: insight, strategies, and practical considerations.

Authors:  Sanket M Shah; Ankitkumar S Jain; Ritu Kaushik; Mangal S Nagarsenker; Maneesh J Nerurkar
Journal:  AAPS PharmSciTech       Date:  2014-06-12       Impact factor: 3.246

7.  Salt stability--effect of particle size, relative humidity, temperature and composition on salt to free base conversion.

Authors:  Yi-Ling Hsieh; Lynne S Taylor
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

8.  Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate.

Authors:  Christopher T John; Wei Xu; Lisa K Lupton; Paul A Harmon
Journal:  Pharm Res       Date:  2013-03-20       Impact factor: 4.200

9.  Bisoprolol and bisoprolol-valsartan compatibility studied by differential scanning calorimetry, nuclear magnetic resonance and X-ray powder diffractometry.

Authors:  Marcin Skotnicki; Juan A Aguilar; Marek Pyda; Paul Hodgkinson
Journal:  Pharm Res       Date:  2014-08-13       Impact factor: 4.200

Review 10.  Oxidation of Drugs during Drug Product Development: Problems and Solutions.

Authors:  Alen Gabrič; Žiga Hodnik; Stane Pajk
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.